Plant Health Care recently signed its second agreement with an industry leader to evaluate its Innatus 3G peptide platform.
The Innatus platform technology allows for the design, screening and production of a large quantity of peptides with diverse bio-stimulant properties. The peptides can improve yields, promote pest and disease resistance, and protect against abiotic stress in a range of crops. Peptides also can complement existing practices by combining them with conventional crop protection chemicals in seed treatment and foliar applications.
Plant Health Care CEO Paul Schmidt said in just five months the company has achieved its 2015 goal of signing at least two evaluation agreements for the platform.
“We are targeting the largest players, and these agreements reflect the potential value they see in our platform,” Schmidt said. “Our dialogue with other major players is ongoing."
Schmidt did not identify specifically which company the second agreement was with.
Organizations in this story
Plant Health Care 2626 Glenwood Ave Raleigh, NC 27608
- Montana lawmakers preserve private-road rights
- Nevada cautions horse owners after reports of EHV-4, strangles
- American Farm Bureau Federation outlines concerns at USDA forum
- Kansas looks for beef trade mission participants
- Project to introduce drought-resistant maize continues in Africa
- American Soybean Association outlines its concerns on Farm Bill
- Commodity Classic set to kick off in San Antonio
- Second-graders enjoy a day of 'Ag Venture'
- Florida offers potentially life-saving app
- Connecticut hopes third time's a charm for conservationists